Plato Investment Management Ltd Makes New Investment in Danaher Corporation $DHR

Plato Investment Management Ltd acquired a new stake in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,926 shares of the conglomerate’s stock, valued at approximately $2,810,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC bought a new position in Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter worth $26,000. Finally, WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter valued at $26,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 0.0%

Shares of Danaher stock opened at $202.51 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a 50-day moving average of $193.14 and a 200-day moving average of $192.91. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market cap of $142.37 billion, a PE ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on DHR shares. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Stifel Nicolaus lowered their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Finally, JPMorgan Chase & Co. reduced their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $228.91.

View Our Latest Stock Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.